stars 1 stars 2 stars 3

Calytrix Bio was founded in 2025 with a mission to transform the lives of patients living with myeloproliferative neoplasms (MPNs). Patients with these complex, progressive blood cancers have long hoped for truly disease-modifying therapies. At Calytrix Bio, we aspire to “change the course by going to the source.” We aim to deliver new therapeutic options, leveraging deep engagement with the MPN community and nimble development execution.

Employees 8 (8 on RocketReach)
Founded 2025
Industry Biotechnology Research

Calytrix Bio Questions

Brad Prosek is the President and CEO of Calytrix Bio.

8 people are employed at Calytrix Bio.

Top Calytrix Bio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users